Your session is about to expire
← Back to Search
Biomaterial
SYNECOR PRE Device for Ventral Hernia (SYN 20-01 Trial)
N/A
Recruiting
Research Sponsored by W.L.Gore & Associates
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 60 months
Awards & highlights
Summary
The SYN 20-01 Study is a non-interventional, prospective, multicenter, multicohort, international, post-market clinical investigation looking into the assessment of GORE® SYNECOR Biomaterial in focused patient populations and in long-term application. Patients with ventral / incisional hernia amenable to hernia mesh repair will be enrolled into two cohorts (US and EU cohort) and followed-up over the period of 60 months.
Eligible Conditions
- Ventral Hernia
- Incisional Hernia
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 60 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~60 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Hernia Recurrence
Secondary study objectives
Adverse Events by Clavien Dindo Classification
Change in Quality of Life (QoL) - Carolinas Comfort Scale (CCS)
Change in Quality of Life (QoL) - SF 36 Questionnaire
+8 moreTrial Design
2Treatment groups
Experimental Treatment
Group I: SYNECOR PRE DeviceExperimental Treatment1 Intervention
Hernia mesh repair with GORE® SYNECOR Preperitoneal Biomaterial
Group II: SYNECOR IP DeviceExperimental Treatment1 Intervention
Hernia mesh repair with GORE® SYNECOR Intraperitoneal Biomaterial
Find a Location
Who is running the clinical trial?
W.L.Gore & AssociatesLead Sponsor
98 Previous Clinical Trials
28,524 Total Patients Enrolled
Share this study with friends
Copy Link
Messenger